Skip to content

Dicyclomine + Diloxanide + Simethicone + Tinidazole

Overview

Medical Information

Dosage Information

Side Effects

Safety Information

Reference Information

Frequently Asked Questions

What is the recommended dosage for Dicyclomine + Diloxanide + Simethicone + Tinidazole?

See "Dosage" section. Consult a specialist and clinical resources due to the limited information regarding this combination medication.

What are the common side effects?

Common side effects include nausea, metallic taste, diarrhea, dry mouth, vomiting, stomach pain, flatulence, weakness, nervousness, headache, blurred vision, dizziness, and sleepiness.

Are there any serious side effects I should be aware of?

Yes, rare but serious side effects include angioedema, apnea, confusion, skin rash, and difficulty breathing. Seek immediate medical attention if these occur.

Can I drink alcohol while taking this medication?

No, alcohol should be avoided as it can interact with tinidazole and worsen side effects like dizziness.

Is this medication safe during pregnancy or breastfeeding?

The safety during pregnancy and breastfeeding is not well established. It should only be used if the potential benefit outweighs the risk. Consult a physician.

What should I do if I miss a dose?

If you miss a dose, take it as soon as you remember. However, if it is almost time for the next dose, skip the missed dose and continue with your regular schedule. Don't double the dose.

How should this medication be stored?

Store below 30°C.

Are there any drug interactions I should be aware of?

Yes, potential drug interactions exist with anticoagulants (e.g., warfarin), alcohol, and lithium. Consult a comprehensive drug interaction resource and/or a pharmacist for detailed information.

What should I tell my doctor before taking this medication?

Inform your doctor about any pre-existing medical conditions, allergies, and other medications you are taking, including over-the-counter drugs and supplements. Discuss any planned pregnancy or breastfeeding.